Matt Jay his hit a rich vein of form for Torquay United Torquay United manager Paul Wotton says striker Matt Jay can continue to improve after scoring in each of his last four appearances.

Torquay United manager Paul Wotton says striker Matt Jay can continue to improve after scoring in each of his last four appearances. The former Exeter City forward joined the Gulls in January ...

Jay Saunders has praised his opposite number as Tonbridge prepare to host Torquay this weekend. Paul Wotton has the Gulls fighting for promotion in his first season in charge at Plainmoor ...

Jay-Z has filed a lawsuit against his former ... had filed her suit in New York without being admitted to Bar of the United States District Court for the Southern District of New York (SDNY ...

LGT Fund Management Co Ltd. acquired a new stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and ...

The acquisition marked Onconetix’s official pivot to the oncology space. Sapirstein, Entero Therapeutics CEO, brings more than three decades of experience to role As executive chairman ...

HC Wainwright reissued their buy rating on shares of United Therapeutics (NASDAQ:UTHR – Free Report) in a report published on Thursday morning,Benzinga reports. HC Wainwright currently has a $ ...

United Therapeutics stock opened at $319.96 on Thursday. United Therapeutics has a 12-month low of $221.53 and a 12-month high of $417.82. The company has a market capitalization of $14.28 billion ...

The United Nations is the world’s principal organization for deliberating matters of peace and security, but its work encompasses far more than peacekeeping and conflict prevention. The UN ...

on paid administrative leave and eliminating 1,600 positions in the United States. Billionaire Elon Musk’s Department of Government Efficiency has led an effort to gut the U.S. Agency for ...

Leerink analyst Roanna Ruiz lowered the firm’s price target on United Therapeutics (UTHR) to $420 from $430 and keeps an Outperform rating on the shares. United Therapeutics’ Q4 earnings ...

United Therapeutics Corporation beats earnings expectations. Reported EPS is $6.19, expectations were $6.1. Operator: Good morning, and welcome to the United Therapeutics Corporation Fourth ...